Evidence map›Paper›PMID 29238632›Full record

ArticleEl Bisturi

A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.

Luis A Figueroa-Jiménez, Amy Lee Cabrera-Márquez, Luis Báez-Díaz, William Cáceres-Perkins

Open access · greenAbstract read
In one paragraph

Article in El Bisturi. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luis A Figueroa-JiménezHematology-Medical Oncology Section, VA Caribbean Healthcare System and San Juan City, Hospital, San Juan, Puerto Rico.
Amy Lee Cabrera-MárquezHematology-Medical Oncology Section, VA Caribbean Healthcare System and San Juan City, Hospital, San Juan, Puerto Rico.
Luis Báez-DíazHematology-Medical Oncology Section, VA Caribbean Healthcare System and San Juan City, Hospital, San Juan, Puerto Rico.
William Cáceres-PerkinsHematology-Medical Oncology Section, VA Caribbean Healthcare System and San Juan City, Hospital, San Juan, Puerto Rico.
VA Caribbean Healthcare System · PR

Funding

Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/LatinosU54CA163068 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI KENNETH Lynn WRIGHT · 2012 to 2026
$23.1M
NCI NIH HHS U54 CA163068
6 · The paper itself

Abstract

Prolymphocytic leukemias (PLLs) are rare mature lymphoid disorders of B- and T-cell subtypes with distinct features and an aggressive clinical course. PLL represents only 2% of all mature lymphocytic leukemias in adults. T-PLL represents 20% of all PLLs cases. T-cell prolymphocytic leukemia (T-PLL) is more rare and more rapidly progressive and aggressive than B-PLL; it is generally resistant to conventional chemotherapy, and historically the median survival has been about 7 months. Clinicians will often only see a case of T-PLL once every 5 to 10 years, which makes recognition of the disorder difficult. The prognosis is poor and there is no curative therapy. We report a 77-year-old male patient with

Indexed as

B-cell Prolymphocytic leukemias (B-PLL)T-cell Prolymphocytic leukemias (T-PLL)

Identifiers

PMID29238632
PMCPMC5726281
OpenAlexW2987405189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.